UPDATE - Canaccord Genuity Upgraded Omeros Corp. (OMER) to Buy; Impressive Efficacy Data From First OMS302 Phase 3 Trial
Tweet
Share
E-mailGet Alerts OMER Hot Sheet
Price: $19.27 +3.44%
Rating Summary:
8 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
8 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
UPDATE - Canaccord Genuity upgraded Omeros Corp. (NASDAQ: OMER) from Hold to Buy, price target raised from $5 to $13.
Analyst, Ritu Baral, said, "Upgrading to BUY, raising target to $13 on increased chance of OMS302 success in eye surgery...Impressive efficacy data from first OMS302 Phase 3 trial gives us high confidence in second Phase 3 data for Q4/12E, a key catalyst. Yesterday, OMER announced the first Phase 3 OMS302 trial hit primary and secondary endpoints and responder analysis with high levels of significance. Given the second Phase 3 closely resembles the first, we think its chance of success is very high."
"We think OMS302 could reach significant market share in the growing cataract and lens replacement surgery market. There are over 3.6M of these procedures in the US alone, and surgery rates are growing."
To see more ratings on OMER, Click Here
Analyst, Ritu Baral, said, "Upgrading to BUY, raising target to $13 on increased chance of OMS302 success in eye surgery...Impressive efficacy data from first OMS302 Phase 3 trial gives us high confidence in second Phase 3 data for Q4/12E, a key catalyst. Yesterday, OMER announced the first Phase 3 OMS302 trial hit primary and secondary endpoints and responder analysis with high levels of significance. Given the second Phase 3 closely resembles the first, we think its chance of success is very high."
"We think OMS302 could reach significant market share in the growing cataract and lens replacement surgery market. There are over 3.6M of these procedures in the US alone, and surgery rates are growing."
To see more ratings on OMER, Click Here
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- OPT Machine Vision Tech Co Ltd (688686:CH) PT Raised to RMB147.60 at Macquarie
- Rockwell Automation (ROK) PT Lowered to $490 at DA Davidson
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
